Clinical Trial Update: A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists

View source ↗

Summary

This completed study assessed real-world awareness and perceptions of systemic inflammation and the role of hsCRP as a biomarker among nephrologists treating at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Chronic Kidney Disease

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD) | Status: COMPLETED